Please wait a minute...
Reviews in Cardiovascular Medicine  2021, Vol. 22 Issue (3): 817-834     DOI: 10.31083/j.rcm2203088
Special Issue: Diet, nutrients and cardiovascular disease prevention
Review Previous articles | Next articles
Dyslipidemia in pediatrician's practice
Alla V. Burlutskaya1, Victoria E. Tril1, *(), Lily V. Polischuk2, Vladimir M. Pokrovskii3, *()
1Department of Pediatrics №2, Kuban State Medical University, 350063 Krasnodar, Russia
2Department of Therapy №2, Kuban State Medical University, 350063 Krasnodar, Russia
3Department of Normal Physiology, Kuban State Medical University, 350063 Krasnodar, Russia
Download:  PDF(511KB)  ( 332 ) Full text   ( 21 )
Export:  BibTeX | EndNote (RIS)      
Atherosclerosis ranks first among cardiovascular system diseases. It is the "disease of the century", and more than 50% of people with circulatory pathology die of it. The clinical manifestation of atherosclerosis is observed at the middle and older ages, but it is known that the pathological process develops much earlier. There has been a clear trend in theoretical and practical cardiology in recent years to study the earliest atherogenic markers. Epidemiological, clinical, and morphological studies have proved the presence in children and adolescents of sexual, endogenous, exogenous, primary, and potentiating risk factors contributing to an early formation of a pathogenic foundation for atherosclerotic cardiovascular diseases. Disorders of lipid metabolism – dyslipidemias are attributed to the most significant risk factor for atherosclerotic cardiovascular diseases. The DLP prevalence in the pediatric population is extremely high. According to the results of conducted global studies, lipid metabolism disorders occur in more than 70% of children and adolescents. It causes the need for timely diagnostic, therapeutic and preventive measures. The need to extrapolate the risk factor concept to childhood age is justified by several reasons, the main of which include the broadest spread of atherosclerosis that has become a global pandemic, genetic determinism, and low variability of the lipid spectrum of blood serum: the levels of lipids and lipoproteins discovered in childhood are stable throughout life and have an independent prognostic value. That is why the most practical significance is inherent to the study of lipid and lipoprotein metabolism, starting in the early periods of lipid and lipoprotein ontogenesis. Since risk factors can be identified at the preclinical stage of the atherosclerotic process, dyslipidemia phenotyping will facilitate identifying children and adolescents at risk of developing cardiovascular pathologies in the future. The study objective is to examine the pathophysiological aspects of lipid and lipoprotein metabolism and examine DLP epidemiology – as the leading atherosclerotic cardiovascular disease risk factor in children and adolescents, DLP classification, modern approaches to DLP diagnosis and management.
Key words:  Children      Adolescents      Risk factors      Atherosclerosis      Dyslipidemia     
Submitted:  22 April 2021      Revised:  02 July 2021      Accepted:  05 July 2021      Published:  24 September 2021     
*Corresponding Author(s): (Victoria E. Tril); (Vladimir M. Pokrovskii)   

Cite this article: 

Alla V. Burlutskaya, Victoria E. Tril, Lily V. Polischuk, Vladimir M. Pokrovskii. Dyslipidemia in pediatrician's practice. Reviews in Cardiovascular Medicine, 2021, 22(3): 817-834.

URL:     OR

[1] Anthony G. Matta, Vanessa Nader, Jerome Roncalli. Management of myocardial infarction with Nonobstructive Coronary Arteries (MINOCA): a subset of acute coronary syndrome patients[J]. Reviews in Cardiovascular Medicine, 2021, 22(3): 625-634.
[2] Guinan Xie, An Yan, Peng Lin, Yi Wang, Liping Guo. Trimethylamine N-oxide—a marker for atherosclerotic vascular disease[J]. Reviews in Cardiovascular Medicine, 2021, 22(3): 787-797.
[3] Xiao-Fei Wang, Meng-Cheng Xu, Cheng-Yu Mao, En-Zhou, Qing He, Xing-Qian Qu, Yu-Qi Fan, Chang-Qian Wang, Jun-Feng Zhang. Predictive and prognostic value of v-set and transmembrane domain-containing 1 expression in monocytes for coronary artery disease[J]. Reviews in Cardiovascular Medicine, 2021, 22(3): 1009-1017.
[4] Arif Gucu, Ozlem Arican Ozluk, Sadik Ahmet Sunbul, Mesut Engin, Ibrahim Burak Seker, Ayse Sunbul. Prognostic nutritional index as a marker of mortality: an observational cohort study of patients undergoing cardiac surgery[J]. Reviews in Cardiovascular Medicine, 2021, 22(2): 499-503.
[5] Sheng-Li Du, Zeng-Qin Jia, Jiu-Chang Zhong, Le-Feng Wang. TRPC5 in cardiovascular diseases[J]. Reviews in Cardiovascular Medicine, 2021, 22(1): 127-135.
[6] Moua Yang, Andaleb Kholmukhamedov. Platelet reactivity in dyslipidemia: atherothrombotic signaling and therapeutic implications[J]. Reviews in Cardiovascular Medicine, 2021, 22(1): 67-81.
[7] Grigore Tinica, Crischentian Brinza, Adrian Covic, Iolanda Valentina Popa, Andrei Tarus, Alberto Emanuel Bacusca, Alexandru Burlacu. Determinants of acute kidney injury after cardiac surgery: a systematic review[J]. Reviews in Cardiovascular Medicine, 2020, 21(4): 601-610.
[8] Yasuhiro Tomita, Takatoshi Kasai. Relationship between cardio-ankle vascular index and obstructive sleep apnea[J]. Reviews in Cardiovascular Medicine, 2020, 21(3): 353-363.
[9] Radwan Al Ali, Davor Vukadinović, Wasim Maziak, Lama Katmeh, Viktoria Schwarz, Felix Mahfoud, Ulrich Laufs, Michael Böhm. Cardiovascular effects of waterpipe smoking: a systematic review and meta-analysis[J]. Reviews in Cardiovascular Medicine, 2020, 21(3): 453-468.
[10] Hao Ding, Ying Zhang, Yujia Liu, Zhilin Liu, Chunxun Shi, Nie Zhichao, Chen Zhehua, Zeng Yanjun. Simulated coronary arterial hemodynamics of myocardial bridging[J]. Reviews in Cardiovascular Medicine, 2019, 20(4): 273-280.
[11] Jin Wang, Xu Geng, Jinghua Sun, Shuquan Zhang, Wenqian Yu, Xueling Zhang, Haixia Liu. The risk of periodontitis for peripheral vascular disease: a systematic review[J]. Reviews in Cardiovascular Medicine, 2019, 20(2): 81-89.
[12] Jennifer G. Robinson, Karol E. Watson. Can We Cure Atherosclerosis?[J]. Reviews in Cardiovascular Medicine, 2018, 19(S1): 20-24.
[13] Jun Zhang, Natalia de Albuquerque Rocha, and Peter A. McCullough. Contribution of ApoCIII to Diabetic Dyslipidemia and Treatment With Volanesorsen[J]. Reviews in Cardiovascular Medicine, 2018, 19(1): 13-19.
[14] Prakash Suryanarayana, Shubha Kollampare, Mohammad Reza Movahed. Anomalous Origin of the Right Coronary Artery From the Left Anterior Descending Artery With Anomalous Course Between the Great Vessels: A Case for Conservative Management With Review of the Literature[J]. Reviews in Cardiovascular Medicine, 2015, 16(3): 221-224.
[15] Vasiliki Katsi, Manolis S. Kallistratos, Antonios N. Pavlidis, Nikos Karpettas, Ioannis Skoumas, Nikonas Pavleros, Athanasios J. Manolis, Christos Pitsavos, Dimitris Tousoulis, Christodoulos Stefanadis, Ioannis Kallikazaros. The Mystery of High-density Lipoprotein: Quantity or Quality? Update on Therapeutic Strategies[J]. Reviews in Cardiovascular Medicine, 2015, 16(1): 9-19.
No Suggested Reading articles found!